Naproxen Sodium Tablet
NDC Package 0363-7510-20
Package Information
Naproxen Sodium tablets is do not take more than directed the smallest effective dose should be useddrink a full glass of water with each doseif taken with food, this product may take longer to workadults and children 12 years and older: take 1 tablet every 8 to 12 hours while symptoms last for the first dose you may take 2 tablets within the first hour do not exceed 2 tablets in any 8- to 12-hour period do not exceed 3 tablets in a 24-hour period children under 12 years: ask a doctor. This formulation utilizes a tablet delivery system. Marketed by Walgreens, this product is identified by NDC 0363-7510 and is authorized under FDA application ANDA202807.
Identification & Billing
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 0363 - Walgreens
- 0363-7510 - Naproxen Sodium
- 0363-7510-20 - 1 BOTTLE, PLASTIC in 1 BOX / 20 TABLET in 1 BOTTLE, PLASTIC
- 0363-7510 - Naproxen Sodium
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (0363-7510). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 0363-7510-20 identifies a specific commercial package of 1 bottle, plastic in 1 box / 20 tablet in 1 bottle, plastic of Naproxen Sodium, a human over the counter drug labeled by Walgreens. This tablet is formulated for oral use and contains naproxen sodium as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Walgreens on January 31, 2020. The current certification is valid through December 31, 2027.
How is this Walgreens product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 00363751020. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Labeler segment to maintain the 5-4-2 structure.